# Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin

> **NCT00973986** · PHASE1 · COMPLETED · sponsor: **Liuhuaqiao Hospital** · enrollment: 20 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00973986
- **Lead sponsor:** Liuhuaqiao Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973986, "Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00973986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*